TEVA 2050 TEVA 2050 Pill: green, capsule/oblong, 14mm
The pill with imprint TEVA 2050 TEVA 2050 (Green, Capsule/Oblong, 14mm) has been identified as Tolterodine Tartrate Extended-Release 2 mg and is used for Urinary Incontinence, Overactive Bladder, and Urinary Frequency. It belongs to the drug class urinary antispasmodics and is not a controlled substance.
Images for TEVA 2050 TEVA 2050
Tolterodine Tartrate Extended-Release
- Imprint
- TEVA 2050 TEVA 2050
- Strength
- 2 mg
- Color
- Green
- Size
- 14.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Urinary antispasmodics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA Inc.
- National Drug Code (NDC)
- 00093-2050 (Discontinued)
See also:
More about tolterodine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (78)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: urinary antispasmodics
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
- Tolterodine monograph
- Tolterodine Tartrate Capsules (FDA)
- Tolterodine Tartrate ER Tablets (FDA)
- Tolterodine Tartrate Tablets (FDA)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.